Dr Andrew Bretherick is as a quantitative geneticist in the Molecular Mechanisms Cluster. He has previously worked on a number of molecular and disease traits, including exploring the genetics of host susceptibility to severe COVID-19. Andrew is also a consultant Anaesthetist working in Chronic Pain Medicine.
